Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01890824 · ClinicalTrials.gov registry record

Fat Metabolism Following Chemotherapy in Breast Cancer

A clinical trial, sponsored by Texas A&M University.

Terminated
Registry status
5
Enrollment target

NCT01890824 is a clinical trial that was terminated before completion, run by Texas A&M University. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01890824 was terminated before completion, sponsored by Texas A&M University.

TERMINATED
Registry status
5 participants
Enrollment target

Study Summary

Following chemotherapy, breast cancer patients primarily gain fat mass and lose muscle mass. Both depletion of muscle and an increase of fat mass in breast cancer patients are related to short survival, and decreased skeletal muscle mass and function may result in fatigue and inactivity, which contributes to fat mass changes and can be responsible for chemo-toxicity and increased mortality. The purpose of this study is to provide detailed insight in chemotherapy related changes in lipid metabolism and gut digestion and absorption of fat in breast cancer patients compared to matched healthy controls. This will provide required information that is necessary to implement new strategies to develop optimal nutritional regimen in breast cancer patients. The hypothesis is that chemotherapy in breast cancer is related to altered gut function and absorption and to increases in fat synthesis that lead to fat accumulation. In addition, we will examine the effect of cancer, chemotherapy, and gender by comparing fat digestion/absorption and fat metabolism of the breast cancer before and after chemotherapy, to aged matched healthy female and male controls.

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2013-08
Est. Completion 2015-10

Sponsor

Texas A&M University

95 total trials

What the Registry Record Tells You About NCT01890824

The ClinicalTrials.gov registry entry for NCT01890824 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01890824 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01890824 about?

NCT01890824 is a clinical study titled "Fat Metabolism Following Chemotherapy in Breast Cancer". Following chemotherapy, breast cancer patients primarily gain fat mass and lose muscle mass. Both depletion of muscle and an increase of fat mass in breast cancer patients are related to short survival, and decreased skeletal muscle mass and function may result in fatigue and inactivity, which contr...

What is the current status of trial NCT01890824?

This trial is currently terminated. The enrollment target is 5 participants. The study started on 2013-08. Estimated completion is 2015-10.

Who is sponsoring clinical trial NCT01890824?

This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.